Physician profile
David Taub
NPI 1891804696
$15,767.04
in general payments reported to CMS, 2019-2025
30 companies · $8,860 in 2025
The $8,860 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $129 · 2021: $23.37 · 2022: $944 · 2023: $993 · 2024: $4,517 · 2025: $8,860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,063 · Food and Beverage: $3,990 · Travel and Lodging: $1,095 · Gift: $187 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,062.50 |
| Food and Beverage | $3,990.00 |
| Travel and Lodging | $1,095.00 |
| Gift | $187.14 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $9,475.47 | 2024-2025 | |
| Urogen Pharma, INC. | $1,972.20 | 2022-2025 | Jelmyto |
| Intuitive Surgical, INC. | $1,789.11 | 2019-2024 | Da Vinci Surgical System |
| Calyxo, INC. | $367.97 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $316.63 | 2022-2025 | Botox |
| Ferring Pharmaceuticals INC. | $272.47 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $269.81 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $228.81 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $158.16 | 2020-2023 | Myrbetriq |
| Blue Earth Diagnostics | $133.45 | 2019-2025 | Posluma |
| Boston Scientific Corporation | $124.76 | 2020-2023 | Rezum Generator |
| Myriad Genetic Laboratories, INC. | $75.27 | 2025 | Prolaris |
| Laborie Medical Technologies Corp. | $58.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Tolmar, INC. | $54.42 | 2023-2025 | Eligard, Jatenzo |
| E.R. Squibb & Sons, L.L.C. | $54.32 | 2019-2024 | Opdualag |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $51.70 | 2023-2025 | Nanoknife |
| C. R. Bard, INC. & Subsidiaries | $46.87 | 2025 | Bard Urinary Drainage Bag |
| Coloplast Corp | $36.17 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Profound Medical Corp. | $33.60 | 2025 | Tulsa-Pro |
| Telix Pharmaceuticals | $32.86 | 2024 | Illuccix |
| Becton, Dickinson and Company | $25.82 | 2024 | Bard Urinary Drainage Bag |
| Dendreon Pharmaceuticals LLC | $23.04 | 2025 | Provenge |
| Immunitybio, INC. | $22.47 | 2025 | |
| Olympus America INC. | $21.65 | 2024 | Itind System |
| Healthtronics Stone Solutions, LLC | $19.68 | 2021 | |
| Bioprotect Medical, INC. | $18.40 | 2025 | Bioprotect Balloon Implant System |
| Pfizer INC. | $18.02 | 2019 | |
| Abc Home Medical Supply, INC. | $16.99 | 2025 | |
| Covidien LP | $13.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.